Nadine Myers

Dr Nadine Myers is a Senior Scientist in Assay Biology at Domainex, an integrated drug discovery CRO based in Cambridge, where she specialises in biophysics. She has extensive experience applying biochemical, biophysical and structural approaches to ligand discovery, target validation and protein degradation research. Nadine completed her PhD at Uppsala University through an industrial doctoral programme within the Marie Skłodowska-Curie European Training Network, Ubimotif, which focused on targeting historically challenging proteins for proteasomal degradation. During her PhD in Professor Helena Danielson’s research group, and in collaboration with industrial partner Beactica Therapeutics, she investigated biochemical strategies for ligand discovery against cancer targets using a broad range of biophysical and structural techniques, including SPR, GCI, NMR and X-ray crystallography. Prior to joining Domainex, Nadine gained industry experience across the biotechnology and pharmaceutica